Pradžia › Smeldžianti multipleinė mieloma › New York
Smeldžianti multipleinė mieloma klinikiniai tyrimai New York
8 tyrimai dėl Smeldžianti multipleinė mieloma ieško dalyvių vietose New York.
Miestai New York
Oficialus tyrimo tekstas (anglų kalba)
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
- Memorial Sloan Kettering Cancer Center, New York
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07393282Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
- Hematology Oncology Associates of CNY at Camillus, Camillus
- Hematology Oncology Associates of Central New York-East Syracuse, East Syracuse
- Mount Sinai Chelsea, New York
- ir dar 2
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-19 · NCT03937635A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
- NYU Langone Health Perlmutter Cancer Center, New York
- Stony Brook University Hospital, Stony Brook
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-08 · NCT06140524A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
- Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- ir dar 1
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-16 · NCT05640843Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
- Roswell Park Cancer Institute, Buffalo
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-12-01 · NCT05312255A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- ir dar 1
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-11-13 · NCT06055894Screening for AL Amyloidosis in Smoldering Multiple Myeloma
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
Renkami dalyviaiStebimasis tyrimas
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2025-08-06 · NCT06365060Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma
- University of Rochester, Rochester
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-02-10 · NCT05597345Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.